Outlook Therapeutics- Warrants Profit Margin

Outlook Therapeutics- Warrants's profit margin stands at -49776.98% as of June 2026. That compares with -8270.57% in the prior-year period — down 501.9% year over year. That is below the Healthcare sector average of 13.89%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Outlook Therapeutics- Warrants reported -49776.98% in profit margin versus -8270.57% a year earlier — a 501.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Outlook Therapeutics- Warrants sits lower the Healthcare benchmark (13.89%) with a profit margin of -49776.98%. That is roughly 358386.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -49776.98% for Outlook Therapeutics- Warrants means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Outlook Therapeutics- Warrants's profit margin evolved across reporting periods, while the comparison chart places OTLKW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.